46 filings
8-K
ABGX
Abgenix Inc
30 Mar 06
Abgenix Announces Stockholder Approval of Acquisition by Amgen
12:00am
8-K
ABGX
Abgenix Inc
21 Feb 06
Results of Operations and Financial Condition
12:00am
8-K
ABGX
Abgenix Inc
23 Dec 05
Other Events
12:00am
8-K
ABGX
Abgenix Inc
19 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
ABGX
Abgenix Inc
15 Dec 05
Amgen to Acquire Abgenix for $22.50 Per Share
12:00am
8-K
0js45xq5o5 z5mw
8 Nov 05
Other Events
12:00am
8-K
j1f1nfc4l
25 Oct 05
Results of Operations and Financial Condition
12:00am
8-K
mzmfc brkx8vsbvyee
27 Sep 05
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
aqnk0pc6 126p
2 Aug 05
Abgenix and Amgen Announce Fda Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer
12:00am
8-K
yxpndoo 47mkyu98l
26 Jul 05
Results of Operations and Financial Condition
12:00am
8-K
zutvxk547n1q
28 Jun 05
Cost Associated with Exit or Disposal Activities
12:00am
8-K
7scz71my lpce55y
26 Apr 05
Results of Operations and Financial Condition
12:00am
8-K
d4cf448ud2rmdxhs5zc
24 Mar 05
Entry into a Material Definitive Agreement
12:00am
8-K
6f6dz2cgq 39xeetjk9
22 Feb 05
Abgenix Announces 2004 Fourth Quarter and Full Year Financial Results
12:00am
8-K
tynj2mi3z4h7m5r4rb
18 Feb 05
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
ir86mixcwfj1 q2h
22 Dec 04
Entry into a Material Definitive Agreement
12:00am
8-K
13fyi3to
16 Dec 04
Unregistered Sales of Equity Securities
12:00am
8-K
l2j7 fglqp
15 Dec 04
Other Events
12:00am
8-K
tdbrnuc 0exxzil
26 Oct 04
Abgenix Announces Third Quarter 2004 Financial Results
12:00am
8-K
z1alxp1he5x5xth3on
8 Sep 04
Entry into a Material Definitive Agreement
12:00am